Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2018-A01255-50 | Other Identifier | IDRCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Suicide is the third leading cause of death in adolescents and young adults in the United States and the second leading cause in European countries.
Depressive disorders are consistently the most prevalent psychiatric disorder among adolescents who attempt suicide with a prevalence ranging from 49% to 64%. Depression in adolescent and young adults is a multifactorial phenomenon, as is the risk of suicidal attempt. To address such problems, effective and accessible treatment is needed, as recommended by the French Health Authority (HAS).
Our primary objective is to demonstrate that a weekly psychotherapeutic intervention reduces the depression level.
The primary assessment criterion is the variation of the clinician Adolescent Depression Rating Scale (ADRSc) from randomisation to month 6.
The study also aims comparing in the 2 randomised groups
Suicide is the third leading cause of death in adolescents and young adults in the United States and the second leading cause in European countries. In France, recent epidemiological data showed that the suicide rate in adolescents aged 15 to 19 is 4.1/100 000 inhabitants. Prevalence of suicidal ideations ranges from 15 to 25% in the general population and lifetime estimates of suicide attempts among adolescents range from 1.3 to 3.8% in males and from 1.5 to 10.1% in females. Reducing suicide and suicide attempts is therefore a key public health target.
Depressive disorders are consistently the most prevalent psychiatric disorder among adolescents who attempt suicide with a prevalence ranging from 49% to 64%. Depression in adolescent and young adults is a multifactorial phenomenon, as is the risk of suicidal attempt.
Being in a situation of failure at school or not having a clear training or work project clearly increases the risk for depression. Some studies have targeted potential high school drop outs as a target for prevention of suicidality.
To address such problems, effective and accessible treatment is needed, as recommended by the French Health Authority (HAS). However, only few studies assess, through a randomized protocol, efficacity and feasibility of psychotherapeutic treatment in psychiatry in general and particularly in this population, although individual psychotherapy is highly recommended in clinical practice for depressed adolescents and young adults.
Our primary objective is to demonstrate that a weekly psychotherapeutic intervention reduces the depression level.
The primary assessment criterion is the variation of the clinician Adolescent Depression Rating Scale (ADRSc) from randomisation to month 6.
Others objectives are the following :
To compare in the 2 randomised groups
To describe, in the whole sample (randomised and not randomised),
- the baseline level of abuse during childhood with the CTQ. The effectiveness of reinsertion activities (jobs, diploma, attendance to the Mission Locale) at 0, 3, 6, 9 and 12 months
To evaluate the sensitivity to change of the French version of the ADRSc.
330 subjects wil be included to have 132 randomized subjects into two arms: sustained psychotherapeutic intervention or usual care.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intervention arm | Experimental | follow weekly psychotherapeutic individual sessions following the IPT method during one year. |
|
| usual care arm | Experimental | continue with the standard follow-up provided by the Mission Locale, including periodic meetings with a referee |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| weekly psychotherapeutic individual sessions | Other | weekly psychotherapeutic individual sessions following the IPT method during one year |
|
| Measure | Description | Time Frame |
|---|---|---|
| Depression level | Defined as the difference of ADRS clinician score (cf. Appendix 18.2.1) between inclusion and 6 month. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| depression assessed at 0, 3, 9 and 12 months | The ADRSc (clinician) questionnaire will be filled out by the assessor at 0, 3 and 9 and 12 months during follow-up visits | at 0, 3, 9 and 12 months |
| suicidal attempts and self-harm attempts |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Randomisation criteria :
Included subjects will be randomised if at least one of the following conditions is met: baseline ADRSc score greater or equal than 8 or abuse and/or deprivation according to the Childhood Trauma Questionnaire (CTQ, short version):
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Antoine Guedeney, PhD | APHP | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bichat hospital | Paris | 75018 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
This study is a comparative, randomised controlled trial that aims at demonstrating the superiority of weekly psychotherapeutic intervention during one year in lowering depression symptoms compared to usual care.
The ratio between intervention and usual care arms will be 1:1.
Not provided
Not provided
Not provided
| Usual care | Other | the standard follow-up provided by the Mission Locale, including periodic meetings with a referee |
|
The number of suicidal attempts and self-harm attempts, at 6 and 12 months
| at 6 and 12 months |
| drop out | The number of drop outs at baseline, 6 and 12 months | at baseline, 6 and 12 months |
| time of the hopelessness | The evolution on time of the hopelessness, assessed at 0, 3, 6, 9 and 12 months | t 0, 3, 6, 9 and 12 months |
| global score on the GHQ28 | 5. The evolution on time of the global score on the GHQ28 and on its 4 subscales (Somatization, Anxiety and Insomnia, Social dysfunction, Depressive mood), assessed at 0, 3, 6, 9 and 12 months | at 0, 3, 6, 9 and 12 months |
| working aIliance | The evolution on time of the working aIliance at 0, 3, 6, 9 and 12 months | at 0, 3, 6, 9 and 12 months |